In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million)
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...